New Melanoma Immunotherapy Shows Strong Promise

New Therapies for Melanoma Treatment
New Therapies for Melanoma Treatment

Traditional forms of cancer treatments like chemotherapy and radiation can be very effective for some patients, although they do have many severe side effects. In addition, not every patient responds well to these treatments, which is why there has been so much research done on various forms of alternative cancer treatment.

The FDA recently granted express approval to a new drug called Keytruda, which is chemically known as pembrolizumab. This powerful new drug treats cancer in a way that’s different from conventional cancer treatments. It actually boosts the body’s natural immune system and readies it to attack the cancer cells.

It’s common for patients receiving chemotherapy to suffer from side effects like nausea, vomiting and hair loss. Whereas in clinical trials, ninety percent of all patients who took Keytruda experienced no side effects whatsoever. The best part of the approval of this new drug is that Keytruda appears to be resulting in much longer life expectancy than other treatment methods. One study of 600 patients resulted in 62% of them making it past the 18-month mark.

Researchers are very hopeful that this is just the start of a great breakthrough in cancer treatment options. It is becoming increasingly apparent that immunotherapy, which is what Keytruda uses, is much more beneficial for patients both in terms of reducing their side effects and improving their overall life expectancy.

Alternative cancer treatments are quickly becoming the norm. It might only be a matter of time before they replace chemotherapy and radiation, simply because they really do work. If you or a loved one is looking for alternative cancer treatments, we would love to help you. Please contact us!